Literature DB >> 10821697

Role of beta Arg211 in the active site of human beta-hexosaminidase B.

Y Hou1, D Vocadlo, S Withers, D Mahuran.   

Abstract

Tay-Sachs or Sandhoff disease results from a deficiency of either the alpha- or the beta-subunits of beta-hexosaminidase A, respectively. These evolutionarily related subunits have been grouped with the "Family 20" glycosidases. Molecular modeling of human hexosaminidase has been carried out on the basis of the three-dimensional structure of a bacterial member of Family 20, Serratia marcescens chitobiase. The primary sequence identity between the two enzymes is only 26% and restricted to their active site regions; therefore, the validity of this model must be determined experimentally. Because human hexosaminidase cannot be functionally expressed in bacteria, characterization of mutagenized hexosaminidase must be carried out using eukaryotic cell expression systems that all produce endogenous hexosaminidase activity. Even small amounts of endogenous enzyme can interfere with accurate K(m) or V(max) determinations. We report the expression, purification, and characterization of a C-terminal His(6)-tag precursor form of hexosaminidase B that is 99.99% free of endogenous enzyme from the host cells. Control experiments are reported confirming that the kinetic parameters of the His(6)-tag precursor are the same as the untagged precursor, which in turn are identical to the mature isoenzyme. Using highly purified wild-type and Arg(211)Lys-substituted hexosaminidase B, we reexamine the role of Arg(211) in the active site. As we previously reported, this very conservative substitution nevertheless reduces k(cat) by 500-fold. However, the removal of all endogenous activity has now allowed us to detect a 10-fold increase in K(m) that was not apparent in our previous study. That this increase in K(m) reflects a decrease in the strength of substrate binding was confirmed by the inability of the mutant isozyme to efficiently bind an immobilized substrate analogue, i.e., a hexosaminidase affinity column. Thus, Arg(211) is involved in substrate binding, as predicted by the chitobiase model, as well as catalysis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10821697      PMCID: PMC2910084          DOI: 10.1021/bi992464j

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  44 in total

1.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

2.  A statistical comparison of parameter estimation for the Michaelis-Menten kinetics of human placental hexosaminidase.

Authors:  R Tommasini; L Endrenyi; P A Taylor; D J Mahuran; J A Lowden
Journal:  Can J Biochem Cell Biol       Date:  1985-03

Review 3.  Biochemical consequences of mutations causing the GM2 gangliosidoses.

Authors:  D J Mahuran
Journal:  Biochim Biophys Acta       Date:  1999-10-08

4.  Mutation in GM2-gangliosidosis B1 variant.

Authors:  K Ohno; K Suzuki
Journal:  J Neurochem       Date:  1988-01       Impact factor: 5.372

5.  Biosynthesis of lysosomal enzymes in fibroblasts. Synthesis as precursors of higher molecular weight.

Authors:  A Hasilik; E F Neufeld
Journal:  J Biol Chem       Date:  1980-05-25       Impact factor: 5.157

6.  The subunit and polypeptide structure of hexosaminidases from human placenta.

Authors:  D Mahuran; J A Lowden
Journal:  Can J Biochem       Date:  1980-04

7.  A new variant of type-AB GM2-gangliosidosis.

Authors:  S C Li; Y Hirabayashi; Y T Li
Journal:  Biochem Biophys Res Commun       Date:  1981-07-30       Impact factor: 3.575

8.  Isolation of cDNA clones coding for the alpha-subunit of human beta-hexosaminidase. Extensive homology between the alpha- and beta-subunits and studies on Tay-Sachs disease.

Authors:  R G Korneluk; D J Mahuran; K Neote; M H Klavins; B F O'Dowd; M Tropak; H F Willard; M J Anderson; J A Lowden; R A Gravel
Journal:  J Biol Chem       Date:  1986-06-25       Impact factor: 5.157

9.  The protein activator specific for the enzymic hydrolysis of GM2 ganglioside in normal human brain and brains of three types of GM2 gangliosidosis.

Authors:  Y Hirabayashi; Y T Li; S C Li
Journal:  J Neurochem       Date:  1983-01       Impact factor: 5.372

10.  Variant of GM2-gangliosidosis with hexosaminidase A having a severely changed substrate specificity.

Authors:  H J Kytzia; U Hinrichs; I Maire; K Suzuki; K Sandhoff
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

View more
  4 in total

1.  Characterization of the Glu and Asp residues in the active site of human beta-hexosaminidase B.

Authors:  Y Hou; D J Vocadlo; A Leung; S G Withers; D Mahuran
Journal:  Biochemistry       Date:  2001-02-20       Impact factor: 3.162

2.  Crystal structure of human beta-hexosaminidase B: understanding the molecular basis of Sandhoff and Tay-Sachs disease.

Authors:  Brian L Mark; Don J Mahuran; Maia M Cherney; Dalian Zhao; Spencer Knapp; Michael N G James
Journal:  J Mol Biol       Date:  2003-04-11       Impact factor: 5.469

3.  Identification of the 6-sulfate binding site unique to alpha-subunit-containing isozymes of human beta-hexosaminidase.

Authors:  R Sharma; H Deng; A Leung; D Mahuran
Journal:  Biochemistry       Date:  2001-05-08       Impact factor: 3.162

4.  A single site in human beta-hexosaminidase A binds both 6-sulfate-groups on hexosamines and the sialic acid moiety of GM2 ganglioside.

Authors:  Rohita Sharma; Scott Bukovac; John Callahan; Don Mahuran
Journal:  Biochim Biophys Acta       Date:  2003-01-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.